(1 - 13 von 20
)
Adaptimmune Appoints Elliot Norry as Chief Medical Officer
www.globenewswire.com
Organizational changes strengthen scientific and clinical development from early to late stage, and accelerate application of translational science...
Close Biotechgate Biotechgate | | Twitter LinkedIn Google+ ...canadianlifesciences.com › gate
canadianlifesciences.com
... patients for the Phase 2 SPEARHEAD-1 trial,” said Elliot Norry, Adaptimmune's acting Chief Medical Officer. “We expect that all sites for SPEARHEAD-1 will be ...
Regenerative Medicine Advanced Therapy Designation ...www.teletrader.com › news › details
www.teletrader.com
... our ADP-A2M4 therapy to market in for patients with synovial sarcoma,” said Elliot Norry, Adaptimmune's acting Chief Medical Officer.
People on the Move | | FDANewswww.fdanews.com › articles ›
www.fdanews.com
Adaptimmune has named Elliot Norry as its senior vice president and chief medical officer. Norry has served as the company's head of clinical ...
sortiert nach Relevanz / Datum